Skip to main content

GS UY2 425 (Propafenone Hydrochloride Extended Release 425 mg)

Pill with imprint GS UY2 425 is Red & White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended Release 425 mg. It is supplied by Prasco Laboratories.

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS UY2 425

Propafenone hydrochloride extended release 425 mg GS UY2 425

Propafenone Hydrochloride Extended Release

Imprint
GS UY2 425
Strength
425 mg
Color
Red & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Prasco Laboratories
Inactive Ingredients
gelatin, hypromelloses, magnesium stearate, ferric oxide red, shellac, sodium lauryl sulfate, soya lecithin, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
66993-0116 (Discontinued) Prasco Laboratories
00173-0826 GlaxoSmithKline

Get help with Imprint Code FAQs.

Related images for "GS UY2 425"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.